• Why is high-sensitivity troponin so controversial?
• How can the new test help improve patient safety and reduce medical costs?
• What approaches and pathways are being used in the United States to help clinicians integrate high-sensitivity troponin into their medical practice?
Drs. Mahler and Gilmore will explore these issues and more, as well as respond to your questions in real-time. Don't miss this chance to review the latest developments in cardiac risk stratification!